Biofrontera (BFRI) EBIT Margin (2020 - 2025)
Biofrontera (BFRI) recorded quarterly EBIT Margin of 26.66% in Q4 2025, up 129.68% quarter-over-quarter from 89.84% in Q3 2025, and up 4029.0% on a YoY basis from 0.65% in Q4 2024.
Biofrontera (BFRI) EBIT Margin (2020 - 2025) Analysis & Trends
Biofrontera's EBIT Margin history runs 6 years deep, the most recent figure standing at 26.66% for Q4 2025.
- In Q4 2025, EBIT Margin rose 4029.0% year-over-year to 26.66%; the TTM figure through Dec 2025 stood at 27.2% (up 1891.0% YoY), while the FY2025 annual figure was 27.21%, up 1890.0% from the prior year.
- EBIT Margin was 26.66% for Q4 2025 at Biofrontera, up from 89.84% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 26.66% in Q4 2025 to a low of 371.6% in Q3 2021.
- Historically, EBIT Margin has averaged 75.72% across 5 years, with a median of 59.57% in 2023.
- The sharpest annual moves came in 2021 and 2022: EBIT Margin plunged 29952 bps in 2021, then soared 28740 bps in 2022.
- A 5-year view of EBIT Margin shows it stood at 20.74% in 2021, then sank by 165 bps to 55.02% in 2022, then soared by 34 bps to 36.48% in 2023, then surged by 63 bps to 13.63% in 2024, then surged by 296 bps to 26.66% in 2025.
- The last three EBIT Margin figures came in at 26.66% (Q4 2025), 89.84% (Q3 2025), and 56.25% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 20.77% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 23.74% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -122.23% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -12.88% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 21.55% |
| 10 | Biofrontera | 8.65 Mn | 2.24 Mn | 14.09 Mn | 26.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26.66% |
| Sep 30, 2025 | -89.84% |
| Jun 30, 2025 | -56.25% |
| Mar 31, 2025 | -52.95% |
| Dec 31, 2024 | -13.63% |
| Sep 30, 2024 | -55.04% |
| Jun 30, 2024 | -64.69% |
| Mar 31, 2024 | -69.10% |
| Dec 31, 2023 | -36.48% |
| Sep 30, 2023 | -51.93% |
| Jun 30, 2023 | -148.75% |
| Mar 31, 2023 | -62.89% |
| Dec 31, 2022 | -55.02% |
| Sep 30, 2022 | -84.20% |
| Jun 30, 2022 | -139.38% |
| Mar 31, 2022 | -31.89% |
| Dec 31, 2021 | -20.74% |
| Sep 30, 2021 | -371.60% |
| Jun 30, 2021 | -62.97% |
| Mar 31, 2021 | -73.78% |